Skip to content

Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes

Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes: A Randomized Crossover Proof-of-Concept Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07692802
Acronym
Bot-Fit T2D St
Enrollment
14
Registered
2026-07-09
Start date
2026-03-02
Completion date
2026-05-24
Last updated
2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus (T2DM)

Keywords

Wearable hip exoskeleton, Bot-Fit, Type 2 diabetes, Postprandial glucose, Glycemic response, Walking

Brief summary

This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in patients with type 2 diabetes. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions in patients with type 2 diabetes.

Detailed description

This study investigated whether walking with a wearable hip exoskeleton could modulate postprandial glycemic and physiological responses in patients with type 2 diabetes. Using a randomized crossover design, each participant completed four experimental conditions in a controlled laboratory setting: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. Postprandial glucose responses were assessed after meal ingestion during each experimental trial. Physiological responses, including heart rate and perceived exertion, were also evaluated to compare the metabolic and perceptual demands of walking with and without the wearable hip exoskeleton. The study was designed as a proof-of-concept trial to examine whether wearable hip exoskeleton-assisted walking may influence postprandial glucose regulation in patients with type 2 diabetes.

Interventions

Participants performed 30 minutes of overground walking while wearing the Bot-Fit wearable hip exoskeleton in Aqua mode during the postprandial period.

Participants performed 30 minutes of overground walking while wearing the Bot-Fit wearable hip exoskeleton in Boost mode during the postprandial period.

BEHAVIORALNon-Assisted Walking

Participants performed 30 minutes of overground walking without wearable hip exoskeleton assistance during the postprandial period.

Sponsors

CHA University
Lead SponsorOTHER
Samsung Electronics
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

The outcomes assessor was masked to the intervention condition during outcome processing and analysis.

Intervention model description

Each participant completed four experimental conditions in a randomized crossover design: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode.

Eligibility

Sex/Gender
ALL
Age
55 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Adults diagnosed with type 2 diabetes mellitus. * Participants who were able to complete walking trials with and without the wearable hip exoskeleton. * Participants who provided written informed consent before participation.

Exclusion criteria

* Participants with unstable cardiovascular, neurological, or musculoskeletal conditions that could affect walking ability or safe participation. * Participants with conditions that could interfere with postprandial glucose assessment. * Participants who were unable to safely use the wearable hip exoskeleton. * Participants who were unable to comply with the study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Incremental Area Under the Curve for Postprandial GlucoseUp to 120 minutes after meal ingestion during each experimental trialIncremental area under the curve for postprandial glucose was calculated during the postprandial measurement period for each experimental condition.

Secondary

MeasureTime frame
Peak Postprandial Glucose ConcentrationUp to 120 minutes after meal ingestion during each experimental trial
Heart Rate ResponseUp to 30 minutes
Rating of Perceived ExertionUp to 30 minutes

Countries

South Korea

Contacts

PRINCIPAL_INVESTIGATORSeung-Bo Park, Ph.D

CHA University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 3, 2026